Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Medicaid And Methadone For Opioid Use Disorder: Expanded Coverage Increased Distribution In 10 States, 2019–24
- Latsko E. , et al.
2. A Discrete-Choice Experiment to Assess Patient Preferences for Long-Acting Injectable Treatments in Opioid Use Disorder in Australia, Finland, Germany, and Italy
- Kabra M. , et al.
3. Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country
- Tantuoyir M.M. , et al.
4. The Impact of Completing X-Waiver Training and Clinical Addiction Exposure on Internal Medicine Residents Treating Patients With Opioid Use Disorder
- Callister C. , et al.
5. Novel Uses of Methadone Under the "72-Hour Rule" to Facilitate Transitions of Care and Low-Dose Buprenorphine Induction in an Outpatient Bridge Clinic
- Shahlapour M. , et al.
6. Male patients’ preferences for opioid use treatment programs
- Amini-Rarani M. , et al.
7. Medication for opioid use disorder in the Arab World: A systematic review
- Alawa J. , et al.
8. Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis
- Shayan S.J. , et al.
9. Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis
- Rajabi A. , et al.
10. Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule
- Laks J. , et al.
11. Optimizing hepatitis C virus (HCV) treatment in a US colocated HCV/opioid agonist therapy program
- Habchi J. , et al.
12. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?
- Ekhtiari H. , et al.
13. Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics
- Taylor L.E. , et al.
15. The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden
- Zhang L. , et al.
16. Correlation between interleukin-6 levels and methadone maintenance therapy outcomes
- Lu R.B. , et al.
17. Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction
- Calcaterra S.L. , et al.
18. Medical complications of opioid use disorder in pregnancy
- Prasad M. , et al.
19. The Global State of Harm Reduction in Prisons
- Sander G. , et al.
20. Molecular diagnosis of occult hepatitis C virus infection in Iranian injection drug users
- Sheikh M. , et al.
21. DOES IT WORK?-a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China
- Zhang J.Y. , et al.
22. Barriers to progressing through a methadone maintenance treatment programme: Perspectives of the clients in the Mid-West of Ireland's drug and alcohol services
- Moran L. , et al.
23. Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice
- Norton B. , et al.
24. Gender differences among patients with Hepatitis C virus undergoing rehabilitation through methadone maintenance treatment
- Massah O. , et al.
25. Opioid use, treatment and harm reduction services: The first report from the Persian Gulf region
- Alam-Mehrjerdi Z. , et al.